Skip to main content

Peer Review reports

From: Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa

Original Submission
11 Sep 2022 Submitted Original manuscript
15 Oct 2022 Reviewed Reviewer Report
18 Oct 2022 Reviewed Reviewer Report
15 Nov 2022 Reviewed Reviewer Report
6 Jan 2023 Author responded Author comments - Mihaly Koltai
Resubmission - Version 2
6 Jan 2023 Submitted Manuscript version 2
13 Jan 2023 Reviewed Reviewer Report
24 Jan 2023 Reviewed Reviewer Report
29 Jan 2023 Reviewed Reviewer Report
10 Feb 2023 Author responded Author comments - Mihaly Koltai
Resubmission - Version 3
10 Feb 2023 Submitted Manuscript version 3
21 Feb 2023 Author responded Author comments - Mihaly Koltai
Resubmission - Version 4
21 Feb 2023 Submitted Manuscript version 4
Publishing
22 Feb 2023 Editorially accepted
31 Mar 2023 Article published 10.1186/s12916-023-02806-w

You can find further information about peer review here.

Back to article page